Glenmark Pharmaceuticals launches Phytonadione Injectable Emulsion USP 10 mg/mL
Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the launch of Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules.
Glenmark's Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules is bioequivalent and therapeutically equivalent to the reference listed drug, Vitamin K1 Injectable Emulsion USP, 10 mg/mL of Hospira, Inc., ANDA 087955.
According to IQVIA sales data for the 12-month period ending November 2024, the Vitamin K1 Injectable Emulsion USP, 10 mg/mL market achieved annual sales of approximately $19.7 million.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content